
|Articles|November 1, 2012
LNG-IUS may have potential in endometrial cancer
Insertion of a levonorgestrel intrauterine system (LNG-IUS) can reverse abnormal endometrial cell growth, according to the results of a small study in high-risk patients, suggesting that the device may have potential in treatment of women with early-stage endometrial cancer who are not candidates for surgery.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Here's what you missed at the The Menopause Society’s 2025 Annual Meeting
2
Contemporary OB/GYN week in review: TMS 2025 recap, menopause guidelines, and more
3
Low-dose dienogest proves effective for endometriosis pain relief
4
Fabienne Decrue, PhD, highlights offspring infection risk from antenatal corticosteroid use
5




















